179 related articles for article (PubMed ID: 29300710)
1. Anti-TNF Therapy Is Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide Cohort.
Brouquet A; Maggiori L; Zerbib P; Lefevre JH; Denost Q; Germain A; Cotte E; Beyer-Berjot L; Munoz-Bongrand N; Desfourneaux V; Rahili A; Duffas JP; Pautrat K; Denet C; Bridoux V; Meurette G; Faucheron JL; Loriau J; Guillon F; Vicaut E; Benoist S; Panis Y;
Ann Surg; 2018 Feb; 267(2):221-228. PubMed ID: 29300710
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
[TBL] [Abstract][Full Text] [Related]
3. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
[TBL] [Abstract][Full Text] [Related]
4. Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery: A Prospective Nationwide Cohort Conducted by the Getaid Chirurgie Group.
Maggiori L; Brouquet A; Zerbib P; Lefevre JH; Denost Q; Germain A; Cotte E; Beyer-Berjot L; Munoz-Bongrand N; Desfourneaux V; Rahili A; Duffas JP; Pautrat K; Denet C; Bridoux V; Meurette G; Faucheron JL; Loriau J; Souche R; Vicaut E; Panis Y; Benoist S;
Ann Surg; 2019 Nov; 270(5):827-834. PubMed ID: 31567506
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
Syed A; Cross RK; Flasar MH
Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
[TBL] [Abstract][Full Text] [Related]
6. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease.
Nasir BS; Dozois EJ; Cima RR; Pemberton JH; Wolff BG; Sandborn WJ; Loftus EV; Larson DW
J Gastrointest Surg; 2010 Dec; 14(12):1859-65; discussion 1865-6. PubMed ID: 20872084
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
[TBL] [Abstract][Full Text] [Related]
8. Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
Fumery M; Seksik P; Auzolle C; Munoz-Bongrand N; Gornet JM; Boschetti G; Cotte E; Buisson A; Dubois A; Pariente B; Zerbib P; Chafai N; Stefanescu C; Panis Y; Marteau P; Pautrat K; Sabbagh C; Filippi J; Chevrier M; Houze P; Jouven X; Treton X; Allez M;
Am J Gastroenterol; 2017 Feb; 112(2):337-345. PubMed ID: 27958285
[TBL] [Abstract][Full Text] [Related]
9. Preoperative oral polymeric diet enriched with transforming growth factor-beta 2 (Modulen) could decrease postoperative morbidity after surgery for complicated ileocolonic Crohn's disease.
Beaupel N; Brouquet A; Abdalla S; Carbonnel F; Penna C; Benoist S
Scand J Gastroenterol; 2017 Jan; 52(1):5-10. PubMed ID: 27553420
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis.
Kopylov U; Ben-Horin S; Zmora O; Eliakim R; Katz LH
Inflamm Bowel Dis; 2012 Dec; 18(12):2404-13. PubMed ID: 22467533
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD.
Moosvi Z; Duong JT; Bechtold ML; Nguyen DL
South Med J; 2021 Feb; 114(2):98-105. PubMed ID: 33537791
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients.
Lightner AL; McKenna NP; Alsughayer A; Loftus EV; Raffals LE; Faubion WA; Moir C
J Pediatr Surg; 2019 Oct; 54(10):2162-2165. PubMed ID: 30773391
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582
[TBL] [Abstract][Full Text] [Related]
14. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.
van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB
Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041
[TBL] [Abstract][Full Text] [Related]
15. [Discontinue anti-TNF-alpha therapy when the Crohn patient needs surgery?].
Gross M
MMW Fortschr Med; 2013 Aug; 155(14):32. PubMed ID: 24006590
[No Abstract] [Full Text] [Related]
16. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
[TBL] [Abstract][Full Text] [Related]
17. Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis.
Yang ZP; Hong L; Wu Q; Wu KC; Fan DM
Int J Surg; 2014; 12(3):224-30. PubMed ID: 24394691
[TBL] [Abstract][Full Text] [Related]
18. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
Lightner AL; Mathis KL; Tse CS; Pemberton JH; Shen B; Kochhar G; Singh A; Dulai PS; Eisenstein S; Sandborn WJ; Parry L; Stringfield S; Hudesman D; Remzi F; Loftus EV
Inflamm Bowel Dis; 2018 Mar; 24(4):871-876. PubMed ID: 29509927
[TBL] [Abstract][Full Text] [Related]
19. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD
Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
[TBL] [Abstract][Full Text] [Related]
20. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn's Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients.
Jouvin I; Lefevre JH; Creavin B; Pitel S; Chafai N; Tiret E; Beaugerie L; Parc Y;
Inflamm Bowel Dis; 2018 Jan; 24(2):422-432. PubMed ID: 29361093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
